EUROPE PLATELET RICH PLASMA MARKET ANALYSIS

Europe Platelet Rich Plasma Market, Product Type (Pure-PRP, Leukocyte-Rich PRP, Pure Platelet Rich Fibrin, Others), By Origin (Autologous, Allogeneic/Homologues), By Application (Orthopaedics, Cosmetic Surgery and Dermatology, Neurosurgery, Cardiothoracic Surgery, General Surgery, Urology, Others), and By Country (U.K., Germany, France, Italy, Spain, Russia, Rest of Europe)-

Published In : Jun 2023
Code : CMI3346
Pages :90
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Europe Platelet Rich Plasma Market- Key Developments

Increasing inorganic growth strategies such as agreements and acquisitions by key players in the market is expected to drive the market groeth in the forecast period.

In May, 2022, Ester Medical, a pharmaceutical company announced that It had signed an agreement with Aesthetic Management for exclusive long-term marketing and distribution of Eclipse PRP and Tropocells in the U.S. market.

In March 2020, EmCyte Corporation, a manufacturer of medical devices announced the acquisition of all of the assets of Cellmedix Holdings, a biotechnology company, including its Centrepid Platelet Concentrator system. EmCyte’s acquisition of Cellmedix Holdings LLC’s (Cellmedix) assets could expands its intellectual property profile and product development capabilities.